Pfizer settles the long-running federal Genotropin probe. This case has ties to Peter Rost, who wrote the book “The Whistleblower” about his dealings with Pfizer regarding this incident.
Novartis’ Zelnorm gets yanked. FDA might consider limited re-introduction at a later date.
Merck scores again with Januvia/metformin combo (Janumet).
Takeda’s Actos for diabetes may slow the thickening of artery walls.
Abbott gets approval for coated (time-released) Niaspan.
Another (early-stage) interesting molecule for fighting cholesterol.
Wyeth’s promising new oncology drug, Torisel, gets its review extended for a few more months. May provide interesting new possibilities for kidney cancer.
J&J/Tibotec’s new AIDS treatment, Prezista, looking very promising.
The “new” Bayer (after merger with Berlex) is officially launched – Bayer Healthcare Pharmaceuticals. They will add jobs in NJ.
Leave a Reply